NDC 50242-064

TARCEVA

Erlotinib Hydrochloride

TARCEVA is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Genentech, Inc.. The primary component is Erlotinib Hydrochloride.

Product ID50242-064_5c1bf1f1-3ef7-4411-9305-b4f4080b769a
NDC50242-064
Product TypeHuman Prescription Drug
Proprietary NameTARCEVA
Generic NameErlotinib Hydrochloride
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2005-04-30
Marketing CategoryNDA / NDA
Application NumberNDA021743
Labeler NameGenentech, Inc.
Substance NameERLOTINIB HYDROCHLORIDE
Active Ingredient Strength150 mg/1
Pharm ClassesKinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 50242-064-01

30 TABLET in 1 BOTTLE (50242-064-01)
Marketing Start Date2005-04-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50242-064-01 [50242006401]

TARCEVA TABLET
Marketing CategoryNDA
Application NumberNDA021743
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2005-04-30

Drug Details

Active Ingredients

IngredientStrength
ERLOTINIB HYDROCHLORIDE150 mg/1

OpenFDA Data

SPL SET ID:57bccb29-1c47-4c64-ab6a-77960a91cc20
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 603203
  • 603206
  • 603208
  • 1088253
  • 1088251
  • 1088255

    • Pharmacological Class

    • Kinase Inhibitor [EPC]
    • Protein Kinase Inhibitors [MoA]
    • Kinase Inhibitor [EPC]
    • Protein Kinase Inhibitors [MoA]

    Medicade Reported Pricing

    50242006401 TARCEVA 150 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "TARCEVA" or generic name "Erlotinib Hydrochloride"

    NDCBrand NameGeneric Name
    50242-062TARCEVAerlotinib hydrochloride
    50242-063TARCEVAerlotinib hydrochloride
    50242-064TARCEVAerlotinib hydrochloride
    51991-890ErlotinibErlotinib Hydrochloride
    51991-891ErlotinibErlotinib Hydrochloride
    51991-892ErlotinibErlotinib Hydrochloride
    72485-217ErlotinibErlotinib hydrochloride
    72485-218ErlotinibErlotinib hydrochloride
    72485-219ErlotinibErlotinib hydrochloride
    0378-7131Erlotinib Hydrochlorideerlotinib hydrochloride
    0378-7132Erlotinib Hydrochlorideerlotinib hydrochloride
    0378-7133Erlotinib Hydrochlorideerlotinib hydrochloride
    42292-051Erlotinib Hydrochlorideerlotinib hydrochloride
    42292-052Erlotinib Hydrochlorideerlotinib hydrochloride
    42292-053Erlotinib Hydrochlorideerlotinib hydrochloride
    46708-565ERLOTINIB HYDROCHLORIDEERLOTINIB HYDROCHLORIDE
    46708-566ERLOTINIB HYDROCHLORIDEERLOTINIB HYDROCHLORIDE
    46708-567ERLOTINIB HYDROCHLORIDEERLOTINIB HYDROCHLORIDE
    62332-565ERLOTINIB HYDROCHLORIDEERLOTINIB HYDROCHLORIDE
    62332-566ERLOTINIB HYDROCHLORIDEERLOTINIB HYDROCHLORIDE
    62332-567ERLOTINIB HYDROCHLORIDEERLOTINIB HYDROCHLORIDE
    69539-090Erlotinib HydrochlorideErlotinib Hydrochloride
    69539-091Erlotinib HydrochlorideErlotinib Hydrochloride
    69539-092Erlotinib HydrochlorideErlotinib Hydrochloride
    72205-080Erlotinib HydrochlorideErlotinib Hydrochloride
    72205-081Erlotinib HydrochlorideErlotinib Hydrochloride
    72205-082Erlotinib HydrochlorideErlotinib Hydrochloride

    Trademark Results [TARCEVA]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    TARCEVA
    TARCEVA
    76397405 not registered Dead/Abandoned
    OSI Pharmaceuticals, Inc.
    2002-04-17
    TARCEVA
    TARCEVA
    76252353 2948536 Live/Registered
    OSI PHARMACEUTICALS, LLC
    2001-05-04
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.